BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23414372)

  • 1. Conference report: a hitchhiker's guide to outsourcing ADME studies: the inside of outsourcing.
    Pritchard JF; Anderson SR; Breuckner C; Premkumar ND; Polli JW
    Bioanalysis; 2013 Feb; 5(4):403-5. PubMed ID: 23414372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioanalytical method transfer considerations of chromatographic-based assays.
    Williard CV
    Bioanalysis; 2016 Jul; 8(13):1409-13. PubMed ID: 27277876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug development process and COVID-19 pandemic: Flourishing era of outsourcing.
    Wasan H; Singh D; Reeta KH; Gupta P; Gupta YK
    Indian J Pharmacol; 2022; 54(5):364-372. PubMed ID: 36537406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biopharma CRO industry in China: landscape and opportunities.
    Xia C; Gautam A
    Drug Discov Today; 2015 Jul; 20(7):794-8. PubMed ID: 25701282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outsourcing chemical synthesis in the drug discovery process.
    Festel G
    Drug Discov Today; 2011 Mar; 16(5-6):237-43. PubMed ID: 21262378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outsourcing lead optimization: constant change is here to stay.
    Clark DE
    Drug Discov Today; 2007 Jan; 12(1-2):62-70. PubMed ID: 17198974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging trends in contract research industry in India.
    Drabu S; Gupta A; Bhadauria A
    Contemp Clin Trials; 2010 Sep; 31(5):419-22. PubMed ID: 20609394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current practice and perspectives in CRO oversight based on a survey performed among members of the German Association of Research-Based Pharmaceutical Companies (vfa).
    Hennig M; Hundt F; Busta S; Mikus S; Sanden PH; Sörgel A; Ruppert T
    Ger Med Sci; 2017; 15():Doc02. PubMed ID: 28163667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outsourcing drug discovery to India and China: from surviving to thriving.
    Subramaniam S; Dugar S
    Drug Discov Today; 2012 Oct; 17(19-20):1055-8. PubMed ID: 22542471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One lab, two firms, many possibilities: On R&D outsourcing in the biopharmaceutical industry.
    Billette de Villemeur E; Versaevel B
    J Health Econ; 2019 May; 65():260-283. PubMed ID: 31158785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biotech outsourcing strategies cmc--biologics stream. June 17, 2010, Copenhagen, Denmark.
    Hamer K
    MAbs; 2010; 2(5):461-5. PubMed ID: 20716956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outsourcing bioanalytical services at Janssen Research and Development: the sequel anno 2017.
    Dillen L; Verhaeghe T
    Bioanalysis; 2017 Aug; 9(15):1195-1201. PubMed ID: 28762758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outsourcing lead optimization: the eye of the storm.
    Clark DE
    Drug Discov Today; 2011 Feb; 16(3-4):147-57. PubMed ID: 21145413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outsourcing to exploit a key asset.
    Meerpoel L; Schroven M; Goris K; Demoen K; Marsden S
    Drug Discov Today; 2006 Jun; 11(11-12):556-60. PubMed ID: 16713908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conference report: reviving pharmaceutical R&D with translational science, regulatory efficiency and innovative models.
    Zhang TT; Weng N; Lee M
    Bioanalysis; 2013 Oct; 5(20):2463-7. PubMed ID: 24138620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outsourcing is in.
    Landhuis E
    Nature; 2018 Apr; 556(7700):263-265. PubMed ID: 29643487
    [No Abstract]   [Full Text] [Related]  

  • 17. The evolution of the Pharma-CRO working relationship: AstraZeneca and Covance.
    Bioanalysis; 2017 Aug; 9(15):1171-1174. PubMed ID: 28795581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outsourcing for product success and restful nights.
    Hale D
    Med Device Technol; 2008; 19(7):32, 34-5. PubMed ID: 19133626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Data is the currency of R&D, and that currency is now generated and traded globally.
    Brown FK; Maliski E; Waller C
    Curr Opin Drug Discov Devel; 2010 May; 13(3):275-8. PubMed ID: 20464800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outsource-ability of high-resolution MS-based DMPK assays.
    Rago B; Negahban A
    Bioanalysis; 2016 Aug; 8(16):1641-4. PubMed ID: 27416917
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.